Exact Sciences Thrive's annual revenues are over $500 million (see exact revenue data) and has over 1,000 employees. It is classified as operating in the Medical Laboratories industry.
What is the company's size? (Annual sales and employees)
What industry is the company in?
Exact Sciences Thrive is a publicly traded company on NCM using the ticker symbol EXAS.
Detailed information on company financials and operating reports can be found here:
NCM: EXAS
Exact Sciences Thrive Annual Revenue and Growth Rate
Note: Exact Sciences Thrive's revenues are gauged from an analysis of company filings.
Investor Activity
Exact Sciences Thrive has actively raised capital from investors. These investors may include private investors, venture capital firms, or other investment vehicles.
Date
Investors
Percent Raised
Target Size
June 16, 2009
11
100%
$8 MM
Complete list of funding rounds and total amounts in the Company Report
Trademark Applications
Trademark applications show the products and services that Exact Sciences Thrive is developing and marketing.
Exact Sciences Thrive's new tradmarks suggest it is investing in R&D and marketing, while expanding into new products or markets.
Trademarks may include brand names, product names, logos and slogans.
Trademark
Date
CANCERGUARD Cancer screening test comprised of molecular diagnostic reagents for detecting DNA, protein, methylation and/or chromosomal changes, abnormalities or mutations; diagnostic test consisting of buffers and reagents for use in cancer testing; Reagents for medical use; Medical diagnostic reagents
07/27/2021
ONCOSEARCH Cancer screening test comprised of molecular diagnostic reagents for detecting DNA, protein, methylation and/or chromosomal changes, abnormalities or mutations; diagnostic test consisting of buffers and reagents for use in cancer testing; Reagents for medical use; Medical diagnostic reagents
07/27/2021
ONCOFIND Providing information to patients in the field of diagnostic screening; providing medical information; providing medical diagnostic services and diagnostic testing; providing genomic and genetic testing for medical purposes
01/29/2020
See all trademarks and details in the Full Report.
Recession Risk
Determine whether Exact Sciences Thrive grew or shrank during the last recession. This is useful in estimating the
financial strength and credit risk of the company.
Compare how recession-proof Exact Sciences Thrive is relative to the industry overall.
While a new recession may strike a particular industry, measuring the
industry and company's robustness during the last recession estimates its ability to weather future recessions.
Market Share of Exact Sciences Thrive's Largest Competitors
A competitive analysis shows these companies are in the same general field as Exact Sciences Thrive, even though they may not compete head-to-head.
These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines.
The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies.
Competitive advantage comes from offering better pricing or superior products/service.
These companies are similar in business line and location to Exact Sciences Thrive.
While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.
These companies are in the same general field as Exact Sciences Thrive and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.